Product sales for the three months ended September 30, 2024 was $597,677 compared to $3,631 in the three months ended September 30, 2023. During the third quarter, the Company recorded $594,705 from ...
The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and ...